Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for YCBD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 4.934M
March 31, 2026 2.968M
December 31, 2025 2.774M
September 30, 2025 3.194M
June 30, 2025 3.785M
March 31, 2025 10.27M
December 31, 2024 9.761M
September 30, 2024 8.618M
June 30, 2024 10.82M
March 31, 2024 11.46M
December 31, 2023 8.058M
September 30, 2023 7.164M
June 30, 2023 7.238M
March 31, 2023 7.898M
December 31, 2022 9.136M
September 30, 2022 9.368M
June 30, 2022 10.54M
March 31, 2022 12.96M
Date Value
December 31, 2021 14.93M
September 30, 2021 21.74M
June 30, 2021 26.24M
March 31, 2021 35.17M
December 31, 2020 38.36M
September 30, 2020 31.66M
June 30, 2020 27.73M
March 31, 2020 20.43M
December 31, 2019 46.27M
September 30, 2019 56.91M
June 30, 2019 75.76M
March 31, 2019 108.25M
December 31, 2018 78.31M
September 30, 2018 0.9985M
June 30, 2018 1.253M
March 31, 2018 0.5487M
December 31, 2017 1.143M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Tilray Brands, Inc. 761.18M
Organogenesis Holdings, Inc. 118.31M
Guardian Pharmacy Services, Inc. 185.94M
Nektar Therapeutics 192.01M
Elite Pharmaceuticals, Inc. 34.84M

Total Liabilities (Quarterly) Related Metrics